supporting innovation with expertise
Thought Leadership
Every member of the Peregrine Bio team is an industry leader in their functional discipline, bringing years worth of experience in multiple product modalities and at every stage of clinical and commercial development.
Bioprocess Online | January 9, 2024
Are Single-Use Technologies Always The Answer?
Single-use technologies have become the default standard for most drug substance manufacturing these days. However, there are enough nuances at play to challenge the belief that SUTs are always the best solution. In this article, Brian Tham looks at both cost and risk factors that may benefit from more attention when developing cGMP manufacturing processes and designing cGMP manufacturing facilities.
Evaluating Biopharma Podcast | March 12, 2023
Brian Tham on Project Management and Continuous Improvement in Biopharma
In this episode of the Evaluating Biopharma podcast, host Ben Locwin speaks with Brian Tham on project management in the pharmaceutical industry, improving the outcome and processes of projects, and how to continue improving processes and operational excellence.
Brian also shares his thoughts on the key differences between biotech and pharmaceuticals and other manufacturing industries, what this means for how development programs are managed, and the next evolutionary step for process improvement.
FasTrain
Breaking Down CMC and Its Roles In Drug Development
Brian Tham created this course for professionals involved in drug development who work within, or adjacent to, CMC functions, including scientists, engineers, regulatory affairs personnel, consultants, and project managers. It is also recommended for researchers and academics seeking to expand their knowledge of CMC strategy and operations for biopharmaceutical development.
Through a combination of lectures, case studies, and interactive discussions, course participants gain knowledge and skills necessary to develop effective CMC strategies for biologics drug development.
redica systems | september 14, 2021
my experience with remote audits
The Covid-19 pandemic brought rapid changes to the biotech and pharma industries. In this article, Peregrine Bio’s CMC and Quality Assurance expert, Fenton Fong, shares insights and lessons learned during this turbulent time.
redica systems | April 21, 2021
QMS for Small Pharma and biotech Firms
Fenton Fong hosts this webinar on strategies and insights in developing a comprehensive QMS for small enterprises.
University of British Columbia
Biomanufacturing and quality control
This two-hour webinar created by Fenton Fong is part of the University of British Columbia’s Micro-certificate in Regulatory Affairs for the Life Sciences program. The program offers a foundational understanding of global regulatory systems, processes, and stakeholders.
